AstraZeneca, China-based CSPC partner to develop novel oral therapies
Under the partnership, both companies will work on pre-clinical candidates targeting chronic diseases, including a small molecule oral therapy for immunological conditions.

A leading resource for the Pharmaceutical industry since 2002
Under the partnership, both companies will work on pre-clinical candidates targeting chronic diseases, including a small molecule oral therapy for immunological conditions.
Give your business an edge with our leading industry insights.
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry